SCHEMBL9529728

SCHEMBL9529728

CC1(C)C=C(N2CCCC2=O)c2cccc(Cl)c2N1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 1/20 0.42
▸ MAPT P10636 1/20 0.36
▸ CES1 P23141 3/20 0.35
▸ NSD2 O96028 1/20 0.35
▸ BCHE P06276 1/20 0.35
▸ DAO P14920 1/20 0.35
▸ GRM5 P41594 2/20 0.34
▸ GRM1 Q13255 2/20 0.34
▸ TSHR P16473 2/20 0.33
▸ HPGD P15428 2/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9530888 0.85 NPC1 (0.35) CNR2CES1GRM5GRM1TSHR
SCHEMBL9532407 0.82 GRM5 (0.36) CNR2GRM5GRM1TSHRHPGD
SCHEMBL9529724 0.76 LRRK2 (0.38) MAPTCES1TSHRHPGDALDH1A1
SCHEMBL9530317 0.71 MEN1 (0.40) MAPTCES1TSHRHPGDALDH1A1
SCHEMBL9587447 0.70 TSHR (0.40) CNR2CES1NSD2TSHRHPGD
SCHEMBL10840374 0.69 NSD2 (0.42) MAPTCES1NSD2BCHEDAO
SCHEMBL9530870 0.68 PGR (0.41) MAPTSMN1; SMN2ALDH1A1CYP1A2CYP2D6
SCHEMBL10840500 0.68 ALDH1A1 (0.53) MAPTCES1NSD2BCHEDAO
SCHEMBL9589108 0.65 LMNA (0.34) MAPTTSHRHPGDPDK2LMNA
SCHEMBL9531924 0.64 ABCC9 (0.41) CNR2ALDH1A1CYP1A2CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0214743-B1 USE OF QUINOLINE DERIVATIVES IN THE MANUFACTURE OF MEDICAMENTS FOR THE TREATMENT OF CEREBROVASCULAR DISORDERS AND CEREBRAL SENILITY BEECHAM GROUP PLC (GB) 1993-05-12 — — EP claimed
EP-0150202-B1 DI/TETRA-HYDROQUINOLINES BEECHAM GROUP PLC (GB) 1988-07-06 — — EP claimed
Send feedback